BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 14732633)

  • 21. Muscle lymphocytic infiltrates in thymoma-associated myasthenia gravis are phenotypically different from those in polymyositis.
    Zamecnik J; Vesely D; Jakubicka B; Simkova L; Pitha J; Schutzner J; Mazanec R; Vogel H
    Neuromuscul Disord; 2007 Dec; 17(11-12):935-42. PubMed ID: 17651972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Focal myositis: report of a case in pediatric age and review of the literature].
    Lorenzo-Sanz G; Egea-Nadal P; García-Villanueva M; Gamir ML; Ocete G; García-Lacalle C
    Rev Neurol; 1998 Sep; 27(157):505-8. PubMed ID: 9774828
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T cell infiltrates in the muscles of patients with dermatomyositis and polymyositis are dominated by CD28null T cells.
    Fasth AE; Dastmalchi M; Rahbar A; Salomonsson S; Pandya JM; Lindroos E; Nennesmo I; Malmberg KJ; Söderberg-Nauclér C; Trollmo C; Lundberg IE; Malmström V
    J Immunol; 2009 Oct; 183(7):4792-9. PubMed ID: 19752224
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution of glucocorticoid receptor alpha and beta subtypes in the idiopathic inflammatory myopathies.
    De Bleecker JL; De Paepe B; Vervaet VL; Arys B; Creus KK; Werbrouck BF; Martin JJ
    Neuromuscul Disord; 2007 Feb; 17(2):186-93. PubMed ID: 17251024
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myeloid dendritic cells in inclusion-body myositis and polymyositis.
    Greenberg SA; Pinkus GS; Amato AA; Pinkus JL
    Muscle Nerve; 2007 Jan; 35(1):17-23. PubMed ID: 16969836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient education pages. Polymyositis.
    Kernich CA
    Neurologist; 2008 May; 14(3):205-6. PubMed ID: 18469679
    [No Abstract]   [Full Text] [Related]  

  • 27. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dysimmune and inflammatory myopathies].
    Authier FJ
    Rev Prat; 2008 Dec; 58(20):2253-60. PubMed ID: 19209656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dermatomyositis and polymyositis associated with malignancy: a 21-year retrospective study.
    András C; Ponyi A; Constantin T; Csiki Z; Szekanecz E; Szodoray P; Dankó K
    J Rheumatol; 2008 Mar; 35(3):438-44. PubMed ID: 18203322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunolocalization of interleukin-1 receptors in the sarcolemma and nuclei of skeletal muscle in patients with idiopathic inflammatory myopathies.
    Grundtman C; Salomonsson S; Dorph C; Bruton J; Andersson U; Lundberg IE
    Arthritis Rheum; 2007 Feb; 56(2):674-87. PubMed ID: 17265504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic options in autoimmune inflammatory myopathies (dermatomyositis, polymyositis, inclusion body myositis).
    Pongratz D
    J Neurol; 2006 Sep; 253 Suppl 5():V64-5. PubMed ID: 16998756
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary aldosteronism simulating polymyositis.
    Tang YC; Wang SK; Yuan WL
    J Rheumatol; 2011 Jul; 38(7):1529-33. PubMed ID: 21724734
    [No Abstract]   [Full Text] [Related]  

  • 33. Polyarteritis nodosa presenting with clinical and radiologic features suggestive of polymyositis.
    Haroon M; Bermingham N; Keohane C; Harney S
    Rheumatol Int; 2012 Apr; 32(4):1079-81. PubMed ID: 21331572
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Difference in adhesion molecule expression (ICAM-1 and VCAM-1) in juvenile and adult dermatomyositis, polymyositis and inclusion body myositis.
    Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Vianna MA; Sachetti S; Marie SK
    Autoimmun Rev; 2006 Feb; 5(2):93-100. PubMed ID: 16431335
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Primary obturator pyomyositis: a diagnostic challenge.
    King RJ; Laugharne D; Kerslake RW; Holdsworth BJ
    J Bone Joint Surg Br; 2003 Aug; 85(6):895-8. PubMed ID: 12931815
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer and myositis: new insights into an old association.
    Levine SM
    Curr Opin Rheumatol; 2006 Nov; 18(6):620-4. PubMed ID: 17053509
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distal-symmetric focal inflammatory myopathy distinct from focal myositis and polymyositis.
    Melzer N; Wessig C; Ulzheimer J; Reiners K; Toyka K; Bendszus M; Stoll G
    Muscle Nerve; 2009 Aug; 40(2):309-12. PubMed ID: 19609922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunolocalization of protectin (CD59) and macrophages in polymyositis and dermatomyositis.
    Gendek-Kubiak H; Gendek EG
    J Neuroimmunol; 2004 Apr; 149(1-2):187-94. PubMed ID: 15020079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Localized nodular myositis--a variation of polymyositis].
    Drewes AM; Hansen ES; Svendsen L
    Ugeskr Laeger; 1993 May; 155(18):1390-1. PubMed ID: 8497974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preservation of in vitro muscle fiber function in dermatomyositis and inclusion body myositis: a single fiber study.
    Krivickas LS; Amato AA; Krishnan G; Murray AV; Frontera WR
    Neuromuscul Disord; 2005 May; 15(5):349-54. PubMed ID: 15833427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.